ArticleJournal of clinical medicine2021
Initial Pro Re Nata Brolucizumab for Exudative AMD: The PROBE Study.
Alper Bilgic et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
11 papers cite it
this papercites it
ArticleJournal of clinical medicine2021
Alper Bilgic et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.